Hydrogel platforms for 3D cardiac tissue engineering and fibrotic disease modelling.
- 1Department of Chemical and Materials Engineering, Faculty of Engineering and Design, The University of Auckland, New Zealand.
- 2The MacDiarmid Institute for Advanced Materials and Nanotechnology, Wellington, New Zealand.
- 3Department of Public Health and Clinical Medicine, Faculty of Medicine, Umeå University, Sweden.
Abstract
Tissue engineering offers significant potential to advance the understanding and treatment of cardiac disease by generating in vitro models that recapitulate myocardial physiology in both healthy and diseased states. Specifically, hydrogel-based systems have been widely employed to engineer 3D cardiac tissues due to their ability to support cell viability and mimic aspects of the extracellular matrix. However, conventional hydrogels are inherently isotropic and electrically insulating, limiting their capacity to reproduce the anisotropic structure and conductive properties of native myocardium. To address these limitations, increasingly sophisticated hydrogel platforms have been developed that incorporate conductive, piezoelectric and/or aligned architectures to enhance electrical coupling, guide tissue organisation and promote cardiomyocyte maturation. These hydrogel-based systems can also be tuned to recapitulate pathological states. Cardiac fibrosis is characterised by increased tissue stiffness, and researchers have sought to model this process by modulating the mechanical microenvironment to induce fibrotic phenotypes. With recently developed hydrogel platforms, mechanical properties can be controlled with both spatial and temporal precision, enabling systematic investigation of how dynamic and heterogeneous stiffness influences tissue formation, remodelling and disease progression. Although these platforms are not yet fully translational, they provide powerful tools to modulate multiple physiological parameters, thereby advancing our understanding of cardiac development and informing strategies to treat prevalent pathological conditions.
Related
- Calcium dysregulation amplifies fibrotic responses to TGFβ in human Friedreich's ataxia fibroblasts
- Beyond myoblasts: DUX4 alters the differentiation landscape and promotes a pro-fibrotic phenotype in mesenchymal stromal cells
- In situ CAR-M engineered by liposomal mRNA nanomedicine remodels fibrotic microenvironment for ameliorating liver fibrosis
- Quercetin Suppresses LCN2 and Restores Autophagy via the MAPK/ERK–mTOR Pathway in Bovine Endometrial Epithelial Cells and Attenuates Fibrotic Remodeling in LPS-Induced Mouse Endometritis
- Benchmarking cell segmentation in two Spatialomics platforms with open-source software
BibTeX
@article{porritt2026hydrogel,
title = {{Hydrogel platforms for 3D cardiac tissue engineering and fibrotic disease modelling.}},
author = {Harrison Porritt and Annika Winbo and Jenny Malmström},
journal = {FEBS open bio},
year = {2026},
month = oct,
doi = {10.1002/2211-5463.70361},
url = {https://europepmc.org/article/MED/42904502},
note = {CC BY},
}
RIS
TY - JOUR
TI - Hydrogel platforms for 3D cardiac tissue engineering and fibrotic disease modelling.
AU - Harrison Porritt
AU - Annika Winbo
AU - Jenny Malmström
PY - 2026
DA - 2026/10/21
JO - FEBS open bio
DO - 10.1002/2211-5463.70361
UR - https://europepmc.org/article/MED/42904502
AB - Tissue engineering offers significant potential to advance the understanding and treatment of cardiac disease by generating in vitro models that recapitulate myocardial physiology in both healthy and diseased states. Specifically, hydrogel-based systems have been widely employed to engineer 3D cardiac tissues due to their ability to support cell viability and mimic aspects of the extracellular matrix. However, conventional hydrogels are inherently isotropic and electrically insulating, limiting their capacity to reproduce the anisotropic structure and conductive properties of native myocardium. To address these limitations, increasingly sophisticated hydrogel platforms have been developed that incorporate conductive, piezoelectric and/or aligned architectures to enhance electrical coupling, guide tissue organisation and promote cardiomyocyte maturation. These hydrogel-based systems can also be tuned to recapitulate pathological states. Cardiac fibrosis is characterised by increased tissue stiffness, and researchers have sought to model this process by modulating the mechanical microenvironment to induce fibrotic phenotypes. With recently developed hydrogel platforms, mechanical properties can be controlled with both spatial and temporal precision, enabling systematic investigation of how dynamic and heterogeneous stiffness influences tissue formation, remodelling and disease progression. Although these platforms are not yet fully translational, they provide powerful tools to modulate multiple physiological parameters, thereby advancing our understanding of cardiac development and informing strategies to treat prevalent pathological conditions.
SN - 2211-5463
ER -